Acute gastrointestinal effects of graded levels of copper in drinking water. by Pizarro, F et al.
Articles
Acute Gastrointestinal Effects of Graded Levels of Copper in Drinking Water
Fernando Pizarro, Manuel Olivares, Ricardo Uauy, Patricia Contreras, Adriana Rebelo, and Virginia Gidi
Instituto de Nutrici6n y Tecnologia de los Alimentos (INTA), Universidad de Chile, Santiago, Chile
Theobjectiv ofthis studywas to determine the acute gastrointestinal effects caused bythe con-
sumption ofdrinkingwaterconinggradedlevels ofadded copper. Sixtyhealy, adultwomen
were randomly assigned to receive copper [Cu(II)] at four concentrations in theirdrinking water
following a latin-square design. Each group (n - 15) received tap waterwith no added copper, 1,
3, and 5 mgCull ofadded coppersulfte for a 2-weekstudyperiod, followed by 1 week ofstan-
dard tap water. The subjecs recorded their water consumption and gaointestinal ymptoms
daily on a special form. The avernge daily consumption ofwater was 1.64 liters per subject,
regardless ofthe amount ofcopper added. Final serum copper, ceruloplamin, and liver enzymes
were mesured in all subjects and were not di&rent from baseline con o. Twenty-one
subjects (35%) recorded gastrointestinal disturbances someime during the study, 9 haddirrhea,.
some with abdominal pain and vomiting and 12 subjects presented abdominal pain, nausea, or
vomiting. There was no association between copper levels in drinking water and diarrhea.
Howev, nausea, abdominalpain, orvomitingwere significantlyrelatedtocopperconcentrations
in water. The recorded incidence rate ofthese symptoms was 5, 2, 17, and 15% while ingesing
waterwith0, 1, 3, and 5 mgCull, respcively (overall x2 = 11.3,p<r0.01; Cu <1 mglversnus Cu
>3 mgIl,x2,r<0.01).Whensubjects interruptedtheirconsumption ofdrinkingwaterwithadded
copper, most symptoms disappe We condude that under the conditions ofthe study, there
was no asociaton between egte copper in drinkingwaterwithin the range of0-5 mg/l and
diarrhea, but a .3 mgCulllevdofionized copperwas associatedwith nausea, abdominalpain, or
vomiting. Additional studies with sufficient numbers ofsubjects are needed to define thresholds
for specific gastrointestinal symptoms with precision and to extrapolate these results to the popu-
lation at large. Key wordol copper, diarrhea, drinking water, gastrointestinal symptoms. Environ
HealthPepect107:117-121 (1999). [Online 12January 1999]
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Exposure to copper results almost exclusive-
ly from food and water intake, although
small fractions come via inhalation and via
skin contact with copper-containing sub-
stances (1-7). Intakes ofcopper atdoses that
exceed physiological requirements are nor-
mally controlled by efficient homeostatic
mechanisms (8,9). Acute copper toxicity is
infrequent in humans and is usually the
consequence ofconsumption ofcontaminat-
ed foodstuffs or beverages, including drink-
ing water, or from accidental or deliberate
ingestion ofhigh quantities of copper salts.
Acute symptoms include excessive saliva-
tion, epigastric pain, nausea, vomiting, and
diarrhea (10-12). Intravascular hemolytic
anemia, acute hepatic failure, acute tubular
renal failure, shock, coma, and death have
been observed in severe copper poisoning
(5,7). Anecdotal reports from isolated occur-
rences suggest that the consumption ofbev-
erages or drinking water contaminated with
copper results in abdominal pain, nausea,
vomiting, and diarrhea in humans.
However, the threshold for gastrointestinal
symptoms of copper in drinking water has
not been precisely established (13) in con-
trolled prospective studies. Furthermore,
most studies have serious methodological
problems, such as uncertainty of copper
content in drinking water or confounding
variables such as waterborne pathogens or
alcohol intake. Demonstration of a causal
relationship between copper ingestion and
gastrointestinal symptoms has therefore
been elusive. The aim of this work was to
study the gastrointestinal effect induced by
exposure to drinkingwaterwith graded lev-
els ofadded soluble copper [Cu (II)].
Materials and Methods
This study was double-blind for the subjects
and prospective in nature. Sixtyhealthyadult
women were randomized into four copper
groups, ingesting 0, 1, 3, and 5 mg ofadded
ionic copper (as CuSO4. 5H20) per liter of
tap water. The corresponding concentrations
ofsulfate anion were 0, 1.5, 4.5, and 7.6
mg/l. Total duration of the study was 11
weeks, which were divided into four 2-week
study periods, with 1 week rest in between.
The average major ion concentrations in
drinkingwaterofthe cityofSantiago are sul-
fate (280 mg/l), calcium (169 mg/I), sodium
(46 mg/l), chloride (68 mg/l), magnesium
(12 mg/l), fluoride (0.6 mg/l), and copper
(0.03 mg/I). Thesubjects were oflow socioe-
conomic status and lived in urban Santiago
in a neighborhood constructed 13 years ago.
All houses were ofsimilar design and had a
copper piping system. Copper content and
pH of drinking water was measured using
the EPA-220.1 method after 1 min at first-
draw tap water. The women who participated
in the studywere healthyadults, didnotwork
outside ofthe home, and were not pregnant
orlactating.
All subjects were informed ofthe details
ofthe project. Those who decided to partic-
ipate signed a written consent form prior to
their inclusion in the study. The protocol
was approved by the Ethics in Human
Research Committee of the Institute of
Nutrition and Food Technology of the
University ofChile.
The 60 women were assigned to four
groups of 15 subjects each, and the order of
copper concentration tested followed a Latin-
square design (Fig. 1), where A =.0 mg Cu/l;
B = 1 mg Cull; C = 3 mg Cull, and D = 5
mg Cull. Thus, every woman served as her
own control because each eventually experi-
enced condition '"A There were no signifi-
cant differences in general characteristics of
the subjects among the groups (Table 1). The
double-blinded nature ofthe studyassured us
that subjects did not know exactlywhat level
of copper they were receiving. The Latin-
square experimental design was used to con-
trol for potential sequence effects and con-
founding variables such as menstrual period,
alcohol consumption, andfood intolerance.
Every week the subjects received seven
dark polypropylene flasks filled with a solu-
tion to add to their drinking water. Each
participant prepared her water every morn-
ing by mixing the solution with tap water
in a graduated 3-liter polypropylene con-
tainer to produce the intended copper con-
centration upon mixing. At the end ofday,
the subject registered on a form the amount
of water ingested and any gastrointestinal
symptoms. That is, each woman recorded
daily her symptoms, including nausea,
vomiting, abdominal pain or cramps, diar-
rhea, and food intolerance. The subjects
also recorded ifthey suffered from headache
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of consumption of copper water, and to
confirm recorded morbidity. If a subject
presented diarrhea, abdominal pain, or
vomiting, she was told not to ingest the
water containing copper for the next 2 days.
If the symptoms disappeared, the subject
Drinkingwater (mg added copper/I)
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Figure 1. Experimental design of study. Sixty women were assigned to four groups of 15 subjects each
with copper concentration patterns of 0, 1, 3, 5 (ABCD); 1, 3, 5, 0 (BCDA); 3, 5, 0, 1 (CDAB); and 5, 0, 1, 3
(DABC) mg Cu(ll)/l.
Table 1. Characteristics of subjects
Sequence of copper concentrations by groups
ABCD BCDA CDAB DABC
n 15 15 15 15
Age (years) 33.1 ±9.0 36.3± 11.0 32.3± 11.9 32.9± 10.8
Weight (kg) 62.3 + 10.4 63.3 + 13.5 64.9 + 10.9 63.9 + 16.8
Height(cm) 157±5 155±6 156±3 158±8
Copper IUD* (n) 6 5 4 6
Abbreviations: A, no added copper; B, 1 mg Cu (11)/I; C, 3 mg Cu (11)/1; D, 5 mg Cu (11)/1; IUD, intrauterine device.
Table 2. Effect of copper in drinking water on copper nutrition status and liver enzymes (geometric mean
1 standard deviation or range)
Study groups
ABCD BCDA CDAB DABC Total
Hemoglobin (g/l)
Baseline 134± 11 141 ±08 134± 13 132± 10 135± 12
End firstperiod 137 ± 12 142 ±09 136 ± 16 133 ± 10 137 ± 13
End study 137 ± 14 143 ± 08 136 ± 16 133 ± 09 137 ± 13
Serum copper (pg/dl)
Baseline 110±21 112±27 107±20 104±27 108±24
End firstperiod 112 ±22 116 ± 19 116 ± 19 114 ± 23 115 ± 21
Endstudy 111 ±28 117±32 117±34 106±34 113±32
Ceruloplasmin (mg/I)
Baseline 364 ± 82 421 ± 155 355 ± 66 364 ± 76 376 ± 105
End firstperiod 356 ± 93 394 ± 108 360 ± 102 344 ± 84 363 ± 99
End study 390 ± 75 438 ± 124 392 ± 88 327 ± 58 387 ± 98
GGT (U/I)
Baseline 12.3 (5.0-30.4) 12.0 (6.7-21.5) 13.1 (8.0-21.4) 7.8(4.7-12.9) 11.1 (5.7-21.8)
End firstperiod 8.8 (2.9-26.5) 8.9 (3.7-21.8) 9.3 (4.6-19.0) 6.6(4.0-10.9) 8.4(3.6-19.4)
End study 6.2(1.8-21.0) 6.9 (3.1-15.1) 6.9 (2.8-16.9) 3.5(2.0-6.3) 5.7 (2.2-14.6)
ALAT (U/L)
Baseline 9.3(3.9-22.3) 10.6(5.3-21.2) 8.0 (2.8-23.2) 8.1 (3.4-19.4) 8.9 (3.7-21.8)
End firstperiod 9.7 (4.9-19.1) 8.4(3.2-21.9) 8.4 (3.9-18.2) 9.4(6.3-14.2) 9.0 (4.3-18.7)
End study 6.3(2.4-16.1) 7.8(3.6-16.9) 9.3(4.1-21.4) 6.7 (2.8-15.9) 7.4(3.1-17.7)
AAT (U/I)
Baseline 10.3(4.1-25.5) 8.9 (4.0-19.6) 8.0(2.5-26.0) 7.9 (3.9-15.8) 8.7 (3.5-21.8)
End firstperiod 6.2(2.4-15.6) 10.2(5.9-17.6) 6.9(2.7-17.9) 5.8(2.8-11.9) 7.1 (3.1-16.3)
End study 8.7 (4.4-17.3) 6.3 (2.8-14.5) 10.6(5.5-20.1) 6.7 (3.2-14.1) 7.9 (3.7-16.9)
Abbreviations: A, no added copper; B, 1 mg Cu (I1)/1; C, 3 mg Cu (11)/1; D,5 mg Cu (11)/1; GGT, i-y-glutamyltransferase; ALAT,
alanine-aminotransferase; AAT, aspartate-aminotransferase.
resumed consumption of the copper drink-
ing water. If the symptoms reappeared dur-
ing in the same study period, the subject
was instructed not to drink the study water
until the next 2-week study period began.
Once each week verification of copper
water concentration was performed by mea-
suring the content of copper in a sample
taken from the water prepared by each of
the subjects. Copper provided by food was
considered in the calculation of copper
intake. On two occasions, the field dietitian
obtained from each subject a 24-hr recall
dietary questionnaire (14).
Blood samples were obtained 1 week
before the study began, on the final day of
the first 2 weeks, and on the final day at the
end of the study to determine copper nutri-
tion status. Serum copper was measured by
atomic absorption spectrophotometry, ceru-
loplasmin by radial immunodiffusion (The
Binding Site, Birmingham, UK), and aspar-
tate-aminotransferase (AAT), alanine-amino-
transferase (ALAT), L-'y-glutamyltransferase
(GGT) by enzymatic assays (Boehringer,
Mannheim, Germany); hemoglobin (Hb)
was also measured (Coulter Electronics Inc.,
Hialeah, FL).
Geometric means for AAT, ALAT, and
GGT were calculated because their distrib-
utions were non-Gaussians. Statistical
analyses were carried out by analysis of
variance (ANOVA), Chi-square tests, or
Fisher's Exact tests.
Results
Serum copper levels at baseline were found
to be within the normal range for women
(65-185 pg/dl). The analyzed liver
enzymes in all subjects were also within
normal ranges. The levels of serum copper,
ceruloplasmin, AAT, ALAT, and GGT
remained within normal limits ofthe base-
line both at the end of first period and at
the end ofthe study (Table 2). There were
no statistically significant differences in any
of the parameters studied when the com-
bined effect of time and group was ana-
lyzed by repeated-measures ANOVA: Hb
(F= 0.23), serum copper (F= 0.34), ceru-
loplasmin (F= 1.48), AAT (F= 1.29),
ALAT (F= 0.65), and GGT (F= 0.53).
Repeated copper intakes from diet mea-
sured by 24-hr recall were 1.5 ± 0.4, 1.7 ±
0.5, 1.8 ± 0.3, and 1.9 ± 0.5 mg/day for
groups ABCD, BCDA, CDAB, and
DABC, respectively [ANOVA, not signifi-
cant (NS)]. No changes were observed in
bodyweight. The pH ofstandard tap water
ranged from 7.3 to 7.8. At this pH range,
99.5% of Cu (II) is dissolved. The copper
content of tap water was found to be below
0.1 mg/I and therefore was not considered
to be a significant source of copper.
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or ifthey were menstruating at the time. At
the end of the day the subjects discarded
the remaining noningested copper water.
A field dietitian visited each home twice
each week to monitor preparation ofdrink-
ing water with copper, to assure compliance
a
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Study water consumption was similar
among groups (Table 3). Seventy percent
of the subjects consumed more than 1.5
liters daily, and only 3% recorded intakes
below 0.5 liters water/day. Many of the
subjects (27%) consumed the study water
without any additives (such as powdered
juice mix), 23% consumed it as tea, and
50% consumed it as tea, with a powdered
juice mix, orwithout additives.
The mean measured concentrations of
copper in drinking water prepared by the
study subjects were 0.02 ± 0.01, 0.89 ±
0.25, 2.87 ± 0.45, and 4.57 ± 0.43 mg
Cu/l for water expected to contain 0, 1, 3
and 5 mg Cu (II)/I, respectively. The sub-
jects' total daily intakes of copper from
water were 0.04 ± 0.02, 1.74 ± 0.66, 4.68
± 2.24, and 7.94 ± 2.69 mg, respectively.
Table 4 shows a summary ofthe specific
observed symptomatology by levels of cop-
per in drinking water. Twenty-one subjects
recorded gastrointestinal disturbances some-
time during the study, 9 reported diarrhea
with or without abdominal pain and vomit-
ing, and the other 12 subjects presented
abdominal pain, nausea, or vomiting. There
was no association between copper levels in
drinking water and diarrhea in the range of
0-5 mg/l, with or without vomiting and
abdominal pain symptoms (x2, NS). None
of the subjects presented episodes of diar-
rheawhen ingesting water without the addi-
tion of copper. Four episodes of diarrhea
occurred at concentrations of1, 3, and 5 mg
Cu/l each. On the other hand, 3, 1, 10, and
9 episodes ofabdominal pain and/or nausea
and/or vomiting were recorded when the
subjects ingested water with 0, 1, 3 and 5
mg Cu/l, respectively (overall X2 = 11.3,
p<0.01; Cu <1 mg/I versus Cu >3 mg/l,
p<0.01). No differences were observed
between 0 and 1 mg Cu/l, nor between 3
10
W .$?. :¢28 ? ., ?. - l:S: $ ............
~~~i ~~~~~~
0.4 S S . # _
0.2
0.0
2 4 5 7
Weeksoffollow-up
and 5 mgCu/l. On discontinuing consump-
tion ofcopper water, the symptoms persist-
ed in subjects ingesting 0 mg Cu/l and dis-
appeared in all subjects consuming drinking
water with copper added. Symptoms reap-
peared in 23 of 27 episodes while subjects
consumed drinking water with 3 and 5 mg
Cull. Nongastrointestinal symptoms indud-
ed seven subjects with headaches and six
with increased salivation when they ingested
water with 3 and 5 mg Cu/l; in contrast,
three and twosubjects exhibited these symp-
toms when they ingested waterwith 0 and 1
mg Cu/l, respectively (Fisher's Exact test,
NS).
Figure 2 shows the gastrointestinal
morbidity over time, independent of cop-
per concentration in water, expressed as the
ratio ofepisodes in each of the weeks rela-
tive to episodes occurring in the first week.
Six of the 12 episodes of diarrhea that
occurred throughout the study were pre-
sented during the first week ofstudy; after-
wards a significant decline was noted (X2
=19.1, p<0.008). The response followed a
polynomial function as noted in Figure 2,
suggesting that tolerance was induced over
time. In contrast, the time distribution of
abdominal pain, nausea, and vomiting was
consistent throughout the study (seven in
Table3. Mean group of studywater intake (I/day)
Sequence Time ofstudy
groups 1-2weeks 4-Sweeks 7-8weeks 10-11 weeks
ABCD 1.90 ± 0.69 1.73 ± 0.60 1.63 ± 0.64 1.61 ± 0.57
BCDA 1.79 ± 0.55 1.58 ± 0.73 1.39 ± 0.77 1.28 ± 0.91
CDAB 1.99 ± 0.61 1.85 ±0.50 1.74 ± 0.68 1.71 ±0.67
DABC 1.57 ±0.53 1.52± 0.59 1.40± 0.56 1.51 ± 0.52
Total 1.81 ± 0.60 1.67 ± 0.61 1.54 ± 0.67 1.52 ± 0.69
Abbreviations: A, no added copper; B, 1 mg Cu(11)/1; C, 3mg Cu (11)/1; D,5 mg Cu (11)/1.
Table 4. Gastrointestinal (Gl) and othersymptoms according to copper concentration in drinking water
Drinking water(mg added Cu/l)
0 1 3 5
Reported symtoms (n= 60) (n= 60) (n= 60) (n=60)
Diarrhea, vomiting, and abdominal pain 0 1 0 0
Diarrhea and vomiting 0 1 0 1
Diarrhea and abdominal pain 0 0 4 0
Diarrhea only 0 2 0 3
Abdominal pain only 2 1 3 2
Vomiting only 0 0 1 2
Nausea only 1 0 6 5
Total GI symptoms 3 5 14 13
Headache 2 1 3 4
Increased salivation 1 1 3 3
Total other symptoms 3 2 6 7
1.0
0.8
0.f
C
S *_=
8 10 11
0.4
0.2
0.0
4 5 7
Weeks offollow-up
8 10 11
Figure 2 Gastrointestinal morbidity byweek ofstudy. (A) Ratio of episodes of diarrhea perweek/episodes in the firstweek(X2, p<0.008) and binomial regression
(y=95.02 - 23.25x+ 1.46x2). (B) Ratio ofepisodes of nausea, abdominal pain, and vomiting perweek/episodes in the firstweek(x2, notsignificant).
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the first period, three in the second, six in
the third, and seven in the last one; 2
2.06, NS).
Discussion
Copper ingested from food and water is
almost never harmful to human health
because the concentrations are low.
Moreover, humans have mechanisms that
maintain an efficient homeostasis ofcopper
through a regulation ofthe absorption and
theexcretion ofthis micronutrient (i.e.,when
intake is high, absorption is low, and vice
versa) (15). In this study, although the sub-
jects ingested >200 mg Cu beyond their esti-
mated needs during the 11 weeks of the
study, no changes in the levels ofserum cop-
per, ceruloplasmin, and liver enzymes were
noted. Based on available information on the
effect ofcopper intake on absorption, we can
speculate that most ofthe extra copper was
not absorbed. This is supported byTumlund
et al. (15), who showed a copper absorption
of 55, 36, and 12% in subjects receiving a
low-copper diet (0.8 mg Cu/day), an ade-
quate-copper diet (1.7 mg Cu/day), and a
high-copperdiet (7.5 mgCu/day), respective-
ly. Furthermore, a large proportion of the
absorbed copperisexcretedviathebile.
An excess in copper intake occasionally
induces diarrhea and gastrointestinal upsets
when ingested acutely (10-12). Hepatic
damage has been reported when copper is
ingested chronically at extremely high
intake, >30 mg/day (16-18). In our study,
the average ingestion of 1.8 liters ofwater
with 5 mg ofCu/l [8.2 mg Cu(II)/day] for
the first 14 days did not produce changes in
liver enzymes. Throughout the study, the
three liver enzymes measured remained sta-
ble and within normal ranges. These results
were expected due to the short duration of
the studyand levels ofcopper intake.
The mean taste threshold for ionic cop-
per is approximately 2.6 mg/l in distilled
water (19). In tap water the taste threshold
is slightly higher (2.5-3.0 mg Cu/l) (20).
Therefore, concentrations at 3 mg Cu/l or
above would be likely detected in the tap
water of Santiago. Thus, gastrointestinal
symptoms would be related, in part, to the
astringent andbitter taste ofthewater.
The average dietary intake of copper
amongthestudypopulation, based on a 24-
hrrecall interview, was 1.7 mgCu/day. This
quantity is found within the range estab-
lished by the "estimated safe and adequate
daily dietary intakes" (ESADDI; 1.5-3
mg/dayforadults) (21) and is similar to that
reported by the International Atomic
Energy Agency (IAEA) in studies of 47
countries thatdemonstrated that the majori-
ty of the countries have an average dietary
intake ofcopperdose to 1.5 mg/day(22.
Tap water was not a significant source
ofdietary copper, as the natural concentra-
tion of this micronutrient was only 0.02
mg/l. As expected, the overall intake ofcop-
per increased when the subjects were intro-
duced to water with added copper. When
consuming water with 1 mg Cu/l, the sub-
jects received 3.5 mg Cu/day (1.8 mg ofCu
from the water and 1.7 mg Cu from their
diet). This is higher than the uppervalue of
the ESADDI. With the level of 3 mg Cu/l
in water, total copper consumption was 7.1
mg/day, which is almost double the
ESADDI. At a level of5 mg Cu/l, the total
consumption of copper was 9.8 mg/day,
approximately three times the upper value
ofESADDI. However, all intake levels were
below the limit of 0.5 mg of copper/kg
body weight per day defined as precaution-
ary intake level (maximum tolerable daily
copper intake) by the Joint Food and
Agricultural Organization of the United
Nations/World Health Organization
(WHO) Expert Committee on Food
Additives (23) in the absence ofan NOAEL
(no-observed-adverse-effect level). Thus,
our study indicates that acute reversible gas-
trointestinal symptoms occur below the
limit provisionally established as safe in
terms ofchronic effects.
The results ofour studyshow that there
is no association between copper levels in
drinking water and diarrhea with or with-
out vomiting or abdominal pain in the
range of0-5 mg/l. At 3 mg Cu/l ofwater, a
significant increase in reported nausea,
abdominal pain, or vomiting occurs. Close
to a third of the subjects presented mild
gastrointestinal disturbances during the
study. Nine women (15%) presented 12
episodes ofdiarrhea, and the remaining 12
(20%) suffered from nausea, abdominal
pain, or vomiting. It is important to recog-
nize that 8 of the 12 episodes of diarrhea
were reportedwithin the first 2 weeks ofthe
study. This was not the case with nausea
and abdominal pain, which were fairly con-
sistent throughout the duration of the
study. The etiology of the diarrhea could
not be ascribed to other factors because the
same subjects did not present diarrheawhen
theytookthewaterwithout added copper.
To explain the distinct behavior in the
frequencyofdiarrheaaccording to theperiod
ofthe study, various hypotheses arise: 1) a
possible placebo effect, 2) the subjects
stopped consuming the copper water, or 3)
there was an adaptation among the subjects
to the higher copper exposure. The placebo
effect among the population in this study
could have been provoked by psychological
concerns that occasionally occur when par-
ticipating in experimental studies. However,
it is not likely that a placebo effect can
explain the diarrhea because the frequency of
other symptoms such as abdominal pain,
nausea, and vomiting had a different distrib-
ution. The fact that the group consuming
water without added copper presented only
two episodes ofgastrointestinal symptoma-
tology does not support the placebo hypoth-
esis either. In fact, the frequency ofgastroin-
testinal symptoms observed in this study is
comparable to the results ofa previous study
in Santiago indicating that apparently
healthywomen self-report 0.22 gastrointesti-
nal episodes per subject per year (24). Our
rate is slighdy higher (0.54), and this could
be explained by the fact that subjects in this
study were asked to report symptoms and
thus may have had a greater sensitivity to
symptoms. We purposely asked them to
record any discomfort they felt. Compliance
was monitored, but we could not be certain
that they prepared and consumed the water
as instructed. Although the population stud-
iedwashighlymotivated tofulfill theiroblig-
ation to drinkthecopperwater as instructed,
it must be noted that in all groups partici-
pant consumption ofthe experimental water
decreased from 1.81 liters in weeks 1 and 2
to 1.52liters inweeks 11 and 12.
By reducing the water consumption,
subjects reduced their copper exposure and
subsequent risk ofdeveloping gastrointesti-
nal upsets. This further suggests that self-
report ofconsumption may be overestimat-
ed. The additional verification of copper
levels inwater, performed bymeasuring the
content ofcopper in the water prepared in
the containers by the subjects demonstrat-
ed that the subjects prepared the copper
watercorrectly.
The possible adaptation to rising cop-
per concentration was best exemplified in
the ABCD group, which received 0, 1, 3,
and 5 mg Cu/l. This was the only group
that did not present episodes of diarrhea,
while the other groups presented three,
three, and two episodes with the introduc-
tion ofwater containing 1, 3, and 5 mg of
Cu, respectively. Moreover, during the last
period in the sequence, none ofthe groups
presented diarrhea, regardless of the con-
centration of copper. The results summa-
rized in Figure 2 strongly support the
hypothesis that subjects adapt to high cop-
per concentrations in terms of occurrence
ofdiarrhea.
A previous series of studies indicated
that copper in drinking water may cause
gastrointestinal disturbances ifthe concen-
tration is sufficiently high. In one retro-
spective study conducted in Nebraska (10),
records ofthe frequency ofdiarrhea among
the subjects who lived in houses with dif-
ferent concentrations of copper in potable
water (<1.3 mg/l, 2-3 mg/l, and >3 mg/l)
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were obtained. Subjects that lived in houses
with levels ofcopper >3 mg/I ofwater pre-
sented a higher frequency ofdiarrhea than
the other groups. It was concluded that a
high risk of developing diarrhea exists for
people ingesting water with copper content
>3 mg/1. Later, within this same popula-
tion, the copper content ofthe water in the
homes of the subjects who presented diar-
rhea and in homes of healthy subjects was
compared, but no differences were found.
This second study invalidated the conclu-
sions established previously. The discrepan-
cy was attributed to the fact that the water
samples in the second study were collected
3 weeks after the report ofthe illness, while
in the first study the samples were collected
7 months after the manifestation ofillness.
Two other published studies (11,12)
have serious methodological problems,
such as not taking certain factors into
account, and so theydo not permit a defin-
itive statement to be made about the gas-
trointestinal effects ofhigh concentrations
of copper in tap water. In our study we
controlled for factors such as diet, alcohol
consumption, and presence of menstrua-
tion, and because randomization included
a no-copper-added group, we could control
for confounders. In our study, 25% ofthe
subjects presented gastrointestinal symp-
toms when they abruptly changed the con-
sumption of potable water from their
homes (0.02 mg Cu/l) for water with 1 mg
Cu/l or more. However, the presence of
diarrhea tended to disappear over time. No
association between copper concentration
and incidence ofdiarrhea was observed.
The limit of 2 mg Cu/l, the provisional
guideline value for copper in drinking water
suggested bytheWorld Health Organization
as safe for human consumption, is below the
3 mg/l that we tested. Another controlled
study in infants carried out by our group
demonstrated that the ingestion of water
with 2 mg Cu(II)/l did not produce more
episodes ofdiarrhea thantheconsumption of
water with <0.1 mg Cu(II)Q1 (25). Clearly,
this study only deals with symptomatology
in adults, but infants and children may per-
haps be affected to a greater degree, as sug-
gested in other studies (12. Therefore, fir-
ther investigation in this area is warranted so
that the appropriate and safe levels for chil-
dren can bedetermined.
In conclusion, our study demonstrates
that copper in drinking water, as ionized
copper, showed no association between
copper levels and diarrhea, although at
concentrations >3 mg/l copper is associated
with an increase in gastrointestinal symp-
toms (nausea, abdominal pain, or vomit-
ing) above baseline. This level ofionic cop-
per in drinking water may be associated
with higher total copper content, as several
copper species found in drinking water are
not fully soluble. Thus, drinking water
with higher copper concentration may be
well tolerated. Further studies are required
to determine the population-based copper
concentration threshold for different gas-
trointestinal symptoms and the specific
response to copper species actually found
in drinkingwater.
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